Associated Papers
Analysis of pathogenic variants in 605 Chinese children with non-syndromic cardiac conotruncal defects based on targeted sequencing.
Ye J et al.
Genomics, 2023
Development and validation of a mutation-based model to predict immunotherapeutic efficacy in NSCLC.
He P et al.
Frontiers in Oncology, 2023
36910641 (PubMed )
Supplement: DataSheet_1.xlsx › Table_S8
Gene mutations in sporadic lymphangioleiomyomatosis and genotype-phenotype correlation analysis.
Huang J et al.
Bmc Pulmonary Medicine, 2022
36117164 (PubMed )
Supplement: 12890_2022_2154_MOESM4_ESM.xlsx › sheet1
High prevalence of somatic PIK3CA and TP53 pathogenic variants in the normal mammary gland tissue of sporadic breast cancer patients revealed by duplex sequencing.
Kostecka A et al.
Npj Breast Cancer, 2022
35768433 (PubMed )
Supplement: 41523_2022_443_MOESM6_ESM.xlsx › Non_-_truncating_variants
Phenotypic spectrum of FGF10-related disorders: a systematic review.
Bzdega K et al.
Peerj, 2022
Mutations in fibroblast growth factor (FGF8) and FGF10 identified in patients with conotruncal defects.
Zhou S et al.
Journal of Translational Medicine, 2020
Aggressive natural killer-cell leukemia mutational landscape and drug profiling highlight JAK-STAT signaling as therapeutic target.
Dufva O et al.
Nature Communications, 2018
29674644 (PubMed )
Supplement: 41467_2018_3987_MOESM6_ESM.xlsx › NKTCL_L19
Select a paper to view details